These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 3334109

  • 1. The use of a 51Cr technique to detect gastrointestinal microbleeding associated with nonsteroidal antiinflammatory drugs.
    Lussier A, Arsenault A, Varady J, de Médicis R, Lussier Y, LeBel E.
    Semin Arthritis Rheum; 1988 Feb; 17(3 Suppl 2):40-5. PubMed ID: 3334109
    [Abstract] [Full Text] [Related]

  • 2. Gastrointestinal microbleeding associated with the use of etodolac, ibuprofen, indomethacin, and naproxen in normal males.
    Salom IL, Jacob G, Jallad N, Perdomo CA, Mullane JF, Weidler D.
    J Clin Pharmacol; 1984 Feb; 24(5-6):240-6. PubMed ID: 6235249
    [Abstract] [Full Text] [Related]

  • 3. Comparative gastrointestinal blood loss associated with placebo, aspirin, and nabumetone as assessed by radiochromium (51Cr).
    Lussier A, Davis A, Lussier Y, Lebel E.
    J Clin Pharmacol; 1989 Mar; 29(3):225-9. PubMed ID: 2786009
    [Abstract] [Full Text] [Related]

  • 4. Etodolac, a new nonsteroidal anti-inflammatory drug: gastrointestinal microbleeding and endoscopic studies.
    Lanza FL, Arnold JD.
    Clin Rheumatol; 1989 Mar; 8 Suppl 1():5-15. PubMed ID: 2525983
    [Abstract] [Full Text] [Related]

  • 5. Radiochromium (chromium-51) evaluation of gastrointestinal blood loss associated with placebo, aspirin, and nabumetone.
    Lussier A, LeBel E.
    Am J Med; 1987 Oct 30; 83(4B):15-8. PubMed ID: 3500642
    [Abstract] [Full Text] [Related]

  • 6. Epidemiology and role of nonsteroidal antiinflammatory drugs in causing gastrointestinal bleeding.
    Lee I, Cryer B.
    Gastrointest Endosc Clin N Am; 2011 Oct 30; 21(4):597-612. PubMed ID: 21944413
    [Abstract] [Full Text] [Related]

  • 7. A randomized trial measuring fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subjects.
    Hunt RH, Bowen B, Mortensen ER, Simon TJ, James C, Cagliola A, Quan H, Bolognese JA.
    Am J Med; 2000 Aug 15; 109(3):201-6. PubMed ID: 10974182
    [Abstract] [Full Text] [Related]

  • 8. The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events.
    Hunt RH, Harper S, Watson DJ, Yu C, Quan H, Lee M, Evans JK, Oxenius B.
    Am J Gastroenterol; 2003 Aug 15; 98(8):1725-33. PubMed ID: 12907325
    [Abstract] [Full Text] [Related]

  • 9. Measurement of non-steroid antiinflammatory drugs induced gastric microbleeding.
    Beró T, Nagy L, Jávor T, Vincze A.
    Acta Physiol Hung; 1992 Aug 15; 80(1-4):281-7. PubMed ID: 1345197
    [Abstract] [Full Text] [Related]

  • 10. Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding.
    Massó González EL, Patrignani P, Tacconelli S, García Rodríguez LA.
    Arthritis Rheum; 2010 Jun 15; 62(6):1592-601. PubMed ID: 20178131
    [Abstract] [Full Text] [Related]

  • 11. Gastrointestinal safety of nonsteroidal antiinflammatory drugs and selective cyclooxygenase-2 inhibitors in patients on warfarin.
    Cheetham TC, Levy G, Niu F, Bixler F.
    Ann Pharmacother; 2009 Nov 15; 43(11):1765-73. PubMed ID: 19809010
    [Abstract] [Full Text] [Related]

  • 12. Gastrointestinal microbleeding: comparisons between benoxaprofen and other nonsteroidal antiinflammatory agents.
    Ridolfo AS, Crabtree RE, Johnson DW, Rockhold FW.
    J Rheumatol Suppl; 1980 Nov 15; 6():36-47. PubMed ID: 6993671
    [Abstract] [Full Text] [Related]

  • 13. Upper gastrointestinal safety with nabumetone.
    Roth SH.
    J Rheumatol Suppl; 1992 Nov 15; 36():74-9. PubMed ID: 1474539
    [Abstract] [Full Text] [Related]

  • 14. Upper gastrointestinal safety evaluation of parecoxib sodium, a new parenteral cyclooxygenase-2-specific inhibitor, compared with ketorolac, naproxen, and placebo.
    Harris SI, Kuss M, Hubbard RC, Goldstein JL.
    Clin Ther; 2001 Sep 15; 23(9):1422-8. PubMed ID: 11589257
    [Abstract] [Full Text] [Related]

  • 15. Gastrointestinal blood loss of oxaprozin and aspirin with placebo control.
    Lussier A, LeBel E, Tétreault L.
    J Clin Pharmacol; 1982 Apr 15; 22(4):173-8. PubMed ID: 6980231
    [Abstract] [Full Text] [Related]

  • 16. Gastrointestinal microbleeding after aspirin and naproxen.
    Lussier A, Arsenault A, Varady J.
    Clin Pharmacol Ther; 1978 Apr 15; 23(4):402-7. PubMed ID: 343970
    [Abstract] [Full Text] [Related]

  • 17. NSAIDs and faecal blood loss in elderly patients with osteoarthritis: is plasma half-life relevant?
    Scharf S, Kwiatek R, Ugoni A, Christophidis N.
    Aust N Z J Med; 1998 Aug 15; 28(4):436-9. PubMed ID: 9777110
    [Abstract] [Full Text] [Related]

  • 18. Gastric microbleeding following single and repeated dosing with naproxen.
    McAlindon ME, Cook GA, Elliott SL, Hawkey CJ, Yeomans ND.
    Aliment Pharmacol Ther; 1995 Dec 15; 9(6):655-9. PubMed ID: 8824653
    [Abstract] [Full Text] [Related]

  • 19. Duodenal mucosal injury with nonsteroidal antiinflammatory drugs.
    Eliakim R, Ophir M, Rachmilewitz D.
    J Clin Gastroenterol; 1987 Aug 15; 9(4):395-9. PubMed ID: 3498747
    [Abstract] [Full Text] [Related]

  • 20. A case study: nonsteroidal antiinflammatory drugs and gastrointestinal bleeding.
    Carson JL.
    J Rheumatol Suppl; 1988 Oct 15; 17():24-7. PubMed ID: 3264583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.